Core Laboratories (CLB) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $12.62 +1.37%
Financial Fact:
Income Tax Expense (Benefit): 2.08M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income Tax Expense (Benefit): 2.08M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.18, $0.02 better than the analyst estimate of $0.16. Revenue for the quarter came in at $118 million versus the consensus estimate of $104.77 million.
GUIDANCE:
Core Laboratories sees Q4 2021 EPS of $0.18-$0.22, versus the consensus of $0.19. Core Laboratories sees Q4 2021 revenue of $121-124 million, versus the consensus of $108 million.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- InspireMD (NSPR) Tops Q2 EPS by 1c
- Tesla to launch Cybercab in Austin this month - report
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
